NCI | Technology Transfer

PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

Read more about PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES

India
202417104351
Filed on 2024-12-30

T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53

Read more about T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53

Japan
2025-020882
Filed on 2025-02-12

TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21

Read more about TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21

Hong Kong
42025102573.0
Filed on 2025-01-22

NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY

Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY

United Kingdom
19707555.9
Filed on 2019-02-08

NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY

Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY

Germany
19707555.9
Filed on 2019-02-08

NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY

Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY

France
19707555.9
Filed on 2019-02-08

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

South Korea
10-2025-7006999
Filed on 2025-02-28

METHODS TO IDENTIFY AND SELECTIVELY EXPAND TUMOR ANTIGEN-SPECIFIC T CELLS

Read more about METHODS TO IDENTIFY AND SELECTIVELY EXPAND TUMOR ANTIGEN-SPECIFIC T CELLS

Patent Cooperation Treaty
PCT/US2025/022247
Filed on 2025-03-31

3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF TYPE II NKT CELLS AND USES THEREOF

Read more about 3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF TYPE II NKT CELLS AND USES THEREOF

US Application 19/069,431
Filed on 2025-03-04

ANTIANGIOGENIC THERAPY IN COMBINATION WITH IMMUNOTOXIN AND ANTI-CD40 TO IMPROVE SURVIVAL IN BRAIN CANCER AND OTHER NEOPLASMS

Read more about ANTIANGIOGENIC THERAPY IN COMBINATION WITH IMMUNOTOXIN AND ANTI-CD40 TO IMPROVE SURVIVAL IN BRAIN CANCER AND OTHER NEOPLASMS

US Application 63/706,247
Filed on 2024-10-11

Subscribe to NCI